Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Citius Announces Change to Primary Endpoint in Mino-Lok® Study

americanpharmaceuticalreviewSeptember 05, 2019

Tag: Citius , Mino-Lok , MLT

PharmaSources Customer Service